Gordon Malcolm Edge
Plus aucun poste en cours
Profil
Gordon Malcolm Edge is the founder of Science Group Plc, which was founded in 1986.
He was also a former Chairman of Sagentia Group AG from 2002 to 2008, a former Non-Executive Director of CMR Fuel Cells Plc from 2005 to 2013, a former Director of Takara Bio Europe AB, and a former Non-Executive Director of ODEON & UCI Cinemas Holdings Ltd.
Anciens postes connus de Gordon Malcolm Edge
| Sociétés | Poste | Fin |
|---|---|---|
CMR Fuel Cells Plc
 CMR Fuel Cells Plc Electronic Equipment/InstrumentsElectronic Technology CMR Fuel Cells Plc develops fuel cell stacks for portable and small stationary power generation applications. The firm offers fuel cell stacks for direct methanol fuel cells which are integrated into fuel cell systems. The company is located in Cambridge, United Kingdom. | Directeur/Membre du Conseil | 20/11/2013 |
Sagentia Group AG
 Sagentia Group AG Miscellaneous Commercial ServicesCommercial Services Sagentia Group AG is a holding company that operates two businesses: consultancy company Scientific Generics Ltd and investment fund Generics Asset Management Ltd. Generics owns interests in over 35 companies and invests in such industries as engineering materials, telecommunications, life sciences, and medical products. It focuses on the UK, US, and European markets. The company owns and operates facilities in Europe, Hong Kong, and the US. | Président | 05/08/2008 |
| SCIENCE GROUP PLC | Fondateur | 01/11/2006 |
ODEON & UCI Cinemas Holdings Ltd.
 ODEON & UCI Cinemas Holdings Ltd. Movies/EntertainmentConsumer Services ODEON & UCI Cinemas Holdings Ltd. is a holding company, which engages in the operation of movie theaters. The company was founded in 1930 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCIENCE GROUP PLC | Commercial Services |
| Entreprise privées | 4 |
|---|---|
Sagentia Group AG
Sagentia Group AG Miscellaneous Commercial ServicesCommercial Services Sagentia Group AG is a holding company that operates two businesses: consultancy company Scientific Generics Ltd and investment fund Generics Asset Management Ltd. Generics owns interests in over 35 companies and invests in such industries as engineering materials, telecommunications, life sciences, and medical products. It focuses on the UK, US, and European markets. The company owns and operates facilities in Europe, Hong Kong, and the US. | Commercial Services |
CMR Fuel Cells Plc
CMR Fuel Cells Plc Electronic Equipment/InstrumentsElectronic Technology CMR Fuel Cells Plc develops fuel cell stacks for portable and small stationary power generation applications. The firm offers fuel cell stacks for direct methanol fuel cells which are integrated into fuel cell systems. The company is located in Cambridge, United Kingdom. | Electronic Technology |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
ODEON & UCI Cinemas Holdings Ltd.
ODEON & UCI Cinemas Holdings Ltd. Movies/EntertainmentConsumer Services ODEON & UCI Cinemas Holdings Ltd. is a holding company, which engages in the operation of movie theaters. The company was founded in 1930 and is headquartered in London, the United Kingdom. | Consumer Services |
